GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sinclair Pharma PLC (XPAR:SPH) » Definitions » Total Long-Term Liabilities

Sinclair Pharma (XPAR:SPH) Total Long-Term Liabilities : €73.17 Mil (As of Jun. 2018)


View and export this data going back to . Start your Free Trial

What is Sinclair Pharma Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Sinclair Pharma's Total Long-Term Liabilities for the quarter that ended in Jun. 2018 was €73.17 Mil.

Sinclair Pharma Total Long-Term Liabilities Historical Data

The historical data trend for Sinclair Pharma's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinclair Pharma Total Long-Term Liabilities Chart

Sinclair Pharma Annual Data
Trend Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Dec17
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34.38 25.21 176.75 184.72 56.10

Sinclair Pharma Semi-Annual Data
Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Jun17 Dec17 Jun18
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 80.20 66.58 64.19 56.10 73.17

Sinclair Pharma Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Sinclair Pharma Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Sinclair Pharma's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinclair Pharma (XPAR:SPH) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sinclair Pharma PLC (XPAR:SPH) » Definitions » Total Long-Term Liabilities
Comparable Companies
XKRX:016580 XKRX:001360 ROCO:6576 ROCO:6472 TPE:1720 TSXV:FLWR XKRX:003060 XKRX:102460 AVDL XKLS:7148 XMAD:RJF XCNQ:OH TSX:RIV BOM:506197 SLDB SHSE:603139 TSX:TGOD SZSE:300254 LSE:AMYT OSTO:ORX
Traded in Other Exchanges
N/A
Address
Website
http://www.sinclairispharma.com
Sinclair Pharma PLC is a United Kingdom-based specialty pharmaceutical company focused on Dermatology, in particular, Aesthetics, Wound care, and Skin care. The group has a direct sales and marketing presence in the top five European markets and a rapidly growing International division concentrated on key emerging markets through long-term multi-product, multi-country, sales & marketing and distribution deals with key strategic partners. The Company's reportable operating segments are International Operations, France, Italy, Germany, UK, and Spain.